当前位置:药药网 / 药品研发 / 美国药品上市后承诺数据库
BEXSERO, Meningococcal Group B Vaccine
申请企业
GlaxoSmithKline Biologicals
药品名称
BEXSERO, Meningococcal Group B Vaccine
承诺描述
To conduct the ongoing study V102_16 to assess the performance of immunologic assays for evaluating the breadth of coverage against diverse Neisseria meningitidis serogroup B strains.